Cite
HARVARD Citation
Tanwar, S. et al. (n.d.). P68 PACIFIC: a phase III, randomised, multicentre, dose escalation, efficacy and safety study examining the effects of treatment with peginterferon alfa-2a in patients with Child's A or B cirrhosis in chronic hepatitis C virus infection. Gut. pp. A38-A39. [Online].